BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38253056)

  • 21. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Vancomycin Bayesian-Estimated Area Under the Curve Versus Trough-Based Dosing.
    Cerenzio J; Truong J
    Ann Pharmacother; 2023 Aug; 57(8):931-939. PubMed ID: 36476049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R; So H; Seo E; Kim M; Lee J
    PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
    Chen Q; Wan J; Shen W; Lin W; Lin X; Huang Z; Lin M; Chen Y
    Pediatr Neonatol; 2022 May; 63(3):247-254. PubMed ID: 35190273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Feasibility Assessment of a Pharmacy-Driven AUC/MIC Vancomycin Dosing Protocol in a Multicenter Hospital System.
    Phillips M; Rose J; Hamel A; Ingemi A
    Microbiol Spectr; 2023 Feb; 11(2):e0331322. PubMed ID: 36840580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention to age: similar dosing regimens lead to different vancomycin levels among older and younger patients.
    Yahav D; Abbas M; Nassar L; Ghrayeb A; Shepshelovich D; Kurnik D; Leibovici L; Paul M
    Age Ageing; 2019 Dec; 49(1):26-31. PubMed ID: 31711101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
    Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
    J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program.
    Mcgrady KA; Benton M; Tart S; Bowers R
    Pharm Pract (Granada); 2020; 18(3):2024. PubMed ID: 33005260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
    Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.
    Arun A; Swamy S; Jacob K; Sharma R; Kohlhoff SA; Hammerschlag MR
    Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
    Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA
    Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.
    Hall RG; Hazlewood KA; Brouse SD; Giuliano CA; Haase KK; Frei CR; Forcade NA; Bell T; Bedimo RJ; Alvarez CA
    BMC Pharmacol Toxicol; 2013 Feb; 14():12. PubMed ID: 23402420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidates for area under the concentration-time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients.
    Hashimoto N; Kimura T; Hamada Y; Niwa T; Hanai Y; Chuma M; Fujii S; Matsumoto K; Shigemi A; Kawamura H; Takahashi Y; Takesue Y
    J Glob Antimicrob Resist; 2021 Dec; 27():12-19. PubMed ID: 34371241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
    Fewel N
    J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Johnston MM; Huang V; Hall ST; Buckley MS; Bikin D; Barletta JF
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115442. PubMed ID: 34192639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.
    Wong S; Selby PR; Reuter SE
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1231. PubMed ID: 38940223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data.
    Yamada Y; Niwa T; Ono Y; Yamada S; Niwa K; Yasue M; Yamamoto T; Sumi K; Otsubo M; Kobayashi R; Suzuki A
    J Antimicrob Chemother; 2023 Dec; 78(12):2933-2937. PubMed ID: 37889089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.